Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
Mark Hj WesselsZoë Y G J van LieropSamantha NoteboomEva M M StrijbisJohannes A HeijstZoé Léonie Elise van KempenBastiaan MoraalFrederik BarkhofBernard Mj UitdehaagMenno Michiel SchoonheimJoep KillesteinCharlotte E TeunissenPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
sGFAP levels related to MRI markers of neuroinflammation and neurodegeneration.
Keyphrases
- multiple sclerosis
- white matter
- magnetic resonance imaging
- contrast enhanced
- traumatic brain injury
- lipopolysaccharide induced
- cerebrospinal fluid
- protein protein
- neuropathic pain
- ionic liquid
- diffusion weighted imaging
- cognitive impairment
- binding protein
- cerebral ischemia
- small molecule
- spinal cord
- inflammatory response
- rheumatoid arthritis
- magnetic resonance
- blood brain barrier